Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: carboplatin|PROCEDURE: Breast surgery|DRUG: AC
Sponsor: Brown University
Collaborators: Women and Infants Hospital of Rhode Island|Rhode Island Hospital|The Miriam Hospital